Get Your Personalized Supplement StackSupplement Stack Quiz

Other Caffeic Acid Derivatives

Also known as: 3-(3-Hydroxyphenyl)prop-2-enoic acid, Caffeic Acid Derivatives, Caffeic Acid Phenethyl Ester (CAPE), Caffeic Acid

Overview

Caffeic acid derivatives are naturally occurring phenolic compounds, categorized as hydroxycinnamic acids, found in various foods like blueberries, kiwis, plums, cherries, and coffee. These compounds are notable for their extensive range of biological activities, including antioxidant, anti-inflammatory, antibacterial, and anticancer properties. Significant research has identified their cytotoxic effects against cancer cells, particularly in pancreatic cancer, while also indicating benefits such as increased platelet counts in thrombocytopenic patients. The derivatives are often enhanced for bioavailability through formulations like liposomal encapsulations, thus increasing their efficacy. Existing studies, including in vitro, in vivo, and clinical trials, affirm the therapeutic potential of caffeic acid derivatives, establishing a well-documented safety profile within recommended usage parameters.

Benefits

Caffeic acid derivatives are associated with several health benefits: 1. Anticancer activity: Research shows significant cytotoxicity against pancreatic cancer cells, with IC50 values between 24.3 and 50.19 µM, showing a reduced impact on normal cells. 2. Platelet-raising effects: In a meta-analysis, caffeic acid tablets demonstrated a standardized mean difference of 1.50 in increasing platelet counts for thrombocytopenia. 3. Antioxidant and anti-inflammatory properties that are beneficial for overall health. 4. Potential support for bone health, although further studies are needed for validation. The evidence supporting these benefits is robust, mainly derived from systematic reviews and randomized controlled trials (RCTs), underscoring the compounds' relevance in oncology and hematology.

How it works

Caffeic acid derivatives exert their effects through various biological mechanisms, prominently through the inhibition of the NF-κB pathway, which regulates immune response, inflammation, and cell survival. Caffeic acid phenethyl ester (CAPE) specifically inhibits NF-κB and 5-lipoxygenase activity, contributing to its anticancer and anti-inflammatory properties. Liposomal formulations enhance cellular uptake and cytotoxicity towards cancer cells while preserving healthy tissues. Additionally, these compounds modulate immune responses, which can lead to increased white blood cell counts and alleviate myelosuppression in patients.

Side effects

Caffeic acid derivatives generally exhibit a favorable safety profile, mainly when used at recommended dosages. Common side effects are minimal, typically reported at less than 5%, with rarer side effects constituting less than 1%. While there are no significant documented interactions with other drugs, caution is advised for individuals on concurrent medications. Pregnant or breastfeeding women, as well as those with chronic health issues, should seek medical advice prior to use. Overall, using caffeic acid derivatives in therapeutic settings should be done under medical supervision to mitigate any unforeseen risks.

Dosage

The effective dosage of caffeic acid derivatives varies based on therapeutic intent. For anticancer effects, in vitro evidence suggests dosages between 18.75 and 150 μM. In the case of treating thrombocytopenia, clinical efficacy is less clearly defined, though caffeic acid tablets have shown promising results. No maximum safe dose has been established, emphasizing the need to avoid high dosages without informed medical guidance. Liposomal formulations may enhance bioavailability, potentially influencing individual dosing strategies. Consistency in dosing remains crucial, although specific timing is not emphasized in available studies.